nodes	percent_of_prediction	percent_of_DWPC	metapath
Terbinafine—CYP2C8—Simvastatin—atherosclerosis	0.0467	0.0764	CbGbCtD
Terbinafine—CYP2C8—Pravastatin—atherosclerosis	0.0457	0.0747	CbGbCtD
Terbinafine—CYP2C8—Lovastatin—atherosclerosis	0.0457	0.0747	CbGbCtD
Terbinafine—CYP2C19—Rosuvastatin—atherosclerosis	0.0422	0.0689	CbGbCtD
Terbinafine—CYP2C19—Simvastatin—atherosclerosis	0.0392	0.0641	CbGbCtD
Terbinafine—CYP2C19—Lovastatin—atherosclerosis	0.0384	0.0627	CbGbCtD
Terbinafine—CYP2D6—Niacin—atherosclerosis	0.0377	0.0616	CbGbCtD
Terbinafine—CYP2C9—Rosuvastatin—atherosclerosis	0.0351	0.0573	CbGbCtD
Terbinafine—CYP2C9—Simvastatin—atherosclerosis	0.0326	0.0533	CbGbCtD
Terbinafine—CYP2C9—Lovastatin—atherosclerosis	0.0319	0.0521	CbGbCtD
Terbinafine—CYP2C9—Pravastatin—atherosclerosis	0.0319	0.0521	CbGbCtD
Terbinafine—CYP2D6—Simvastatin—atherosclerosis	0.0298	0.0487	CbGbCtD
Terbinafine—CYP2D6—Pravastatin—atherosclerosis	0.0292	0.0477	CbGbCtD
Terbinafine—CYP2D6—Lovastatin—atherosclerosis	0.0292	0.0477	CbGbCtD
Terbinafine—CYP3A4—Ezetimibe—atherosclerosis	0.0204	0.0333	CbGbCtD
Terbinafine—CYP3A4—Rosuvastatin—atherosclerosis	0.0204	0.0333	CbGbCtD
Terbinafine—CYP3A4—Simvastatin—atherosclerosis	0.019	0.031	CbGbCtD
Terbinafine—CYP3A4—Pravastatin—atherosclerosis	0.0185	0.0303	CbGbCtD
Terbinafine—CYP3A4—Lovastatin—atherosclerosis	0.0185	0.0303	CbGbCtD
Terbinafine—Angioedema—Rosuvastatin—atherosclerosis	0.000574	0.00257	CcSEcCtD
Terbinafine—Hepatitis—Simvastatin—atherosclerosis	0.000572	0.00256	CcSEcCtD
Terbinafine—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.000571	0.00256	CcSEcCtD
Terbinafine—Jaundice—Niacin—atherosclerosis	0.000571	0.00256	CcSEcCtD
Terbinafine—Erythema multiforme—Ezetimibe—atherosclerosis	0.000567	0.00254	CcSEcCtD
Terbinafine—Jaundice—Pravastatin—atherosclerosis	0.000562	0.00252	CcSEcCtD
Terbinafine—Cough—Rosuvastatin—atherosclerosis	0.000548	0.00246	CcSEcCtD
Terbinafine—Angiopathy—Ezetimibe—atherosclerosis	0.000544	0.00244	CcSEcCtD
Terbinafine—Immune system disorder—Ezetimibe—atherosclerosis	0.000542	0.00243	CcSEcCtD
Terbinafine—Erythema multiforme—Simvastatin—atherosclerosis	0.000541	0.00242	CcSEcCtD
Terbinafine—Alopecia—Lovastatin—atherosclerosis	0.000541	0.00242	CcSEcCtD
Terbinafine—Myalgia—Rosuvastatin—atherosclerosis	0.000535	0.0024	CcSEcCtD
Terbinafine—Arthralgia—Rosuvastatin—atherosclerosis	0.000535	0.0024	CcSEcCtD
Terbinafine—Alopecia—Ezetimibe—atherosclerosis	0.00053	0.00237	CcSEcCtD
Terbinafine—Mental disorder—Ezetimibe—atherosclerosis	0.000526	0.00235	CcSEcCtD
Terbinafine—Hepatitis—Niacin—atherosclerosis	0.000525	0.00235	CcSEcCtD
Terbinafine—Flatulence—Lovastatin—atherosclerosis	0.000525	0.00235	CcSEcCtD
Terbinafine—Hypoaesthesia—Niacin—atherosclerosis	0.000523	0.00234	CcSEcCtD
Terbinafine—Erythema—Ezetimibe—atherosclerosis	0.000522	0.00234	CcSEcCtD
Terbinafine—Dysgeusia—Lovastatin—atherosclerosis	0.000522	0.00234	CcSEcCtD
Terbinafine—Hepatitis—Pravastatin—atherosclerosis	0.000517	0.00232	CcSEcCtD
Terbinafine—Confusional state—Rosuvastatin—atherosclerosis	0.000517	0.00232	CcSEcCtD
Terbinafine—Hypoaesthesia—Pravastatin—atherosclerosis	0.000515	0.00231	CcSEcCtD
Terbinafine—Flatulence—Ezetimibe—atherosclerosis	0.000515	0.00231	CcSEcCtD
Terbinafine—Muscle spasms—Lovastatin—atherosclerosis	0.000512	0.00229	CcSEcCtD
Terbinafine—Infection—Rosuvastatin—atherosclerosis	0.00051	0.00228	CcSEcCtD
Terbinafine—Visual impairment—Niacin—atherosclerosis	0.000506	0.00227	CcSEcCtD
Terbinafine—Alopecia—Simvastatin—atherosclerosis	0.000506	0.00226	CcSEcCtD
Terbinafine—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000503	0.00225	CcSEcCtD
Terbinafine—Muscle spasms—Ezetimibe—atherosclerosis	0.000502	0.00225	CcSEcCtD
Terbinafine—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000502	0.00225	CcSEcCtD
Terbinafine—Vision blurred—Lovastatin—atherosclerosis	0.000502	0.00225	CcSEcCtD
Terbinafine—Mental disorder—Simvastatin—atherosclerosis	0.000501	0.00225	CcSEcCtD
Terbinafine—Visual impairment—Pravastatin—atherosclerosis	0.000499	0.00223	CcSEcCtD
Terbinafine—Erythema—Simvastatin—atherosclerosis	0.000498	0.00223	CcSEcCtD
Terbinafine—Ill-defined disorder—Lovastatin—atherosclerosis	0.000494	0.00221	CcSEcCtD
Terbinafine—Eye disorder—Niacin—atherosclerosis	0.000491	0.0022	CcSEcCtD
Terbinafine—Flatulence—Simvastatin—atherosclerosis	0.000491	0.0022	CcSEcCtD
Terbinafine—Tinnitus—Niacin—atherosclerosis	0.00049	0.00219	CcSEcCtD
Terbinafine—Erythema multiforme—Pravastatin—atherosclerosis	0.000489	0.00219	CcSEcCtD
Terbinafine—Dysgeusia—Simvastatin—atherosclerosis	0.000488	0.00218	CcSEcCtD
Terbinafine—Angioedema—Lovastatin—atherosclerosis	0.000487	0.00218	CcSEcCtD
Terbinafine—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000485	0.00217	CcSEcCtD
Terbinafine—Anaemia—Ezetimibe—atherosclerosis	0.000483	0.00216	CcSEcCtD
Terbinafine—Tinnitus—Pravastatin—atherosclerosis	0.000482	0.00216	CcSEcCtD
Terbinafine—Malaise—Lovastatin—atherosclerosis	0.00048	0.00215	CcSEcCtD
Terbinafine—Muscle spasms—Simvastatin—atherosclerosis	0.000479	0.00214	CcSEcCtD
Terbinafine—Vertigo—Lovastatin—atherosclerosis	0.000478	0.00214	CcSEcCtD
Terbinafine—Angioedema—Ezetimibe—atherosclerosis	0.000477	0.00214	CcSEcCtD
Terbinafine—Angiopathy—Niacin—atherosclerosis	0.000477	0.00213	CcSEcCtD
Terbinafine—Malaise—Ezetimibe—atherosclerosis	0.000471	0.00211	CcSEcCtD
Terbinafine—Vision blurred—Simvastatin—atherosclerosis	0.000469	0.0021	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000467	0.00209	CcSEcCtD
Terbinafine—Alopecia—Niacin—atherosclerosis	0.000464	0.00208	CcSEcCtD
Terbinafine—Ill-defined disorder—Simvastatin—atherosclerosis	0.000462	0.00207	CcSEcCtD
Terbinafine—Paraesthesia—Rosuvastatin—atherosclerosis	0.000461	0.00206	CcSEcCtD
Terbinafine—Anaemia—Simvastatin—atherosclerosis	0.00046	0.00206	CcSEcCtD
Terbinafine—Erythema—Niacin—atherosclerosis	0.000457	0.00205	CcSEcCtD
Terbinafine—Alopecia—Pravastatin—atherosclerosis	0.000457	0.00205	CcSEcCtD
Terbinafine—Cough—Ezetimibe—atherosclerosis	0.000456	0.00204	CcSEcCtD
Terbinafine—Angioedema—Simvastatin—atherosclerosis	0.000455	0.00204	CcSEcCtD
Terbinafine—Arthralgia—Lovastatin—atherosclerosis	0.000453	0.00203	CcSEcCtD
Terbinafine—Myalgia—Lovastatin—atherosclerosis	0.000453	0.00203	CcSEcCtD
Terbinafine—Chest pain—Lovastatin—atherosclerosis	0.000453	0.00203	CcSEcCtD
Terbinafine—Anxiety—Lovastatin—atherosclerosis	0.000452	0.00202	CcSEcCtD
Terbinafine—Dyspepsia—Rosuvastatin—atherosclerosis	0.000451	0.00202	CcSEcCtD
Terbinafine—Flatulence—Niacin—atherosclerosis	0.000451	0.00202	CcSEcCtD
Terbinafine—Malaise—Simvastatin—atherosclerosis	0.000449	0.00201	CcSEcCtD
Terbinafine—Discomfort—Lovastatin—atherosclerosis	0.000448	0.00201	CcSEcCtD
Terbinafine—Vertigo—Simvastatin—atherosclerosis	0.000448	0.002	CcSEcCtD
Terbinafine—Arthralgia—Ezetimibe—atherosclerosis	0.000445	0.00199	CcSEcCtD
Terbinafine—Chest pain—Ezetimibe—atherosclerosis	0.000445	0.00199	CcSEcCtD
Terbinafine—Myalgia—Ezetimibe—atherosclerosis	0.000445	0.00199	CcSEcCtD
Terbinafine—Flatulence—Pravastatin—atherosclerosis	0.000444	0.00199	CcSEcCtD
Terbinafine—Dry mouth—Lovastatin—atherosclerosis	0.000443	0.00199	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000442	0.00198	CcSEcCtD
Terbinafine—Dysgeusia—Pravastatin—atherosclerosis	0.000441	0.00198	CcSEcCtD
Terbinafine—Muscle spasms—Niacin—atherosclerosis	0.00044	0.00197	CcSEcCtD
Terbinafine—Discomfort—Ezetimibe—atherosclerosis	0.000439	0.00197	CcSEcCtD
Terbinafine—Pain—Rosuvastatin—atherosclerosis	0.000439	0.00196	CcSEcCtD
Terbinafine—Confusional state—Lovastatin—atherosclerosis	0.000438	0.00196	CcSEcCtD
Terbinafine—Dry mouth—Ezetimibe—atherosclerosis	0.000435	0.00195	CcSEcCtD
Terbinafine—Anaphylactic shock—Lovastatin—atherosclerosis	0.000435	0.00195	CcSEcCtD
Terbinafine—Muscle spasms—Pravastatin—atherosclerosis	0.000433	0.00194	CcSEcCtD
Terbinafine—Infection—Lovastatin—atherosclerosis	0.000432	0.00193	CcSEcCtD
Terbinafine—Vision blurred—Niacin—atherosclerosis	0.000431	0.00193	CcSEcCtD
Terbinafine—Confusional state—Ezetimibe—atherosclerosis	0.00043	0.00193	CcSEcCtD
Terbinafine—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000426	0.00191	CcSEcCtD
Terbinafine—Thrombocytopenia—Lovastatin—atherosclerosis	0.000426	0.00191	CcSEcCtD
Terbinafine—Vision blurred—Pravastatin—atherosclerosis	0.000424	0.0019	CcSEcCtD
Terbinafine—Arthralgia—Simvastatin—atherosclerosis	0.000424	0.0019	CcSEcCtD
Terbinafine—Myalgia—Simvastatin—atherosclerosis	0.000424	0.0019	CcSEcCtD
Terbinafine—Chest pain—Simvastatin—atherosclerosis	0.000424	0.0019	CcSEcCtD
Terbinafine—Infection—Ezetimibe—atherosclerosis	0.000424	0.0019	CcSEcCtD
Terbinafine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000423	0.00189	CcSEcCtD
Terbinafine—Anxiety—Simvastatin—atherosclerosis	0.000423	0.00189	CcSEcCtD
Terbinafine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000419	0.00188	CcSEcCtD
Terbinafine—Discomfort—Simvastatin—atherosclerosis	0.000419	0.00188	CcSEcCtD
Terbinafine—Nervous system disorder—Ezetimibe—atherosclerosis	0.000418	0.00187	CcSEcCtD
Terbinafine—Angioedema—Niacin—atherosclerosis	0.000418	0.00187	CcSEcCtD
Terbinafine—Ill-defined disorder—Pravastatin—atherosclerosis	0.000418	0.00187	CcSEcCtD
Terbinafine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000417	0.00187	CcSEcCtD
Terbinafine—Anaemia—Pravastatin—atherosclerosis	0.000416	0.00186	CcSEcCtD
Terbinafine—Anorexia—Lovastatin—atherosclerosis	0.000414	0.00186	CcSEcCtD
Terbinafine—Skin disorder—Ezetimibe—atherosclerosis	0.000414	0.00185	CcSEcCtD
Terbinafine—Angioedema—Pravastatin—atherosclerosis	0.000412	0.00184	CcSEcCtD
Terbinafine—Vertigo—Niacin—atherosclerosis	0.000411	0.00184	CcSEcCtD
Terbinafine—Confusional state—Simvastatin—atherosclerosis	0.00041	0.00184	CcSEcCtD
Terbinafine—Urticaria—Rosuvastatin—atherosclerosis	0.000407	0.00182	CcSEcCtD
Terbinafine—Anaphylactic shock—Simvastatin—atherosclerosis	0.000407	0.00182	CcSEcCtD
Terbinafine—Malaise—Pravastatin—atherosclerosis	0.000406	0.00182	CcSEcCtD
Terbinafine—Abdominal pain—Rosuvastatin—atherosclerosis	0.000405	0.00182	CcSEcCtD
Terbinafine—Vertigo—Pravastatin—atherosclerosis	0.000405	0.00181	CcSEcCtD
Terbinafine—Infection—Simvastatin—atherosclerosis	0.000404	0.00181	CcSEcCtD
Terbinafine—Cough—Niacin—atherosclerosis	0.000399	0.00179	CcSEcCtD
Terbinafine—Thrombocytopenia—Simvastatin—atherosclerosis	0.000398	0.00178	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000396	0.00177	CcSEcCtD
Terbinafine—Cough—Pravastatin—atherosclerosis	0.000393	0.00176	CcSEcCtD
Terbinafine—Paraesthesia—Lovastatin—atherosclerosis	0.00039	0.00175	CcSEcCtD
Terbinafine—Arthralgia—Niacin—atherosclerosis	0.000389	0.00174	CcSEcCtD
Terbinafine—Myalgia—Niacin—atherosclerosis	0.000389	0.00174	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000388	0.00174	CcSEcCtD
Terbinafine—Anorexia—Simvastatin—atherosclerosis	0.000388	0.00174	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000387	0.00173	CcSEcCtD
Terbinafine—Chest pain—Pravastatin—atherosclerosis	0.000383	0.00172	CcSEcCtD
Terbinafine—Myalgia—Pravastatin—atherosclerosis	0.000383	0.00172	CcSEcCtD
Terbinafine—Arthralgia—Pravastatin—atherosclerosis	0.000383	0.00172	CcSEcCtD
Terbinafine—Paraesthesia—Ezetimibe—atherosclerosis	0.000383	0.00171	CcSEcCtD
Terbinafine—Dyspepsia—Lovastatin—atherosclerosis	0.000383	0.00171	CcSEcCtD
Terbinafine—Anxiety—Pravastatin—atherosclerosis	0.000382	0.00171	CcSEcCtD
Terbinafine—Dry mouth—Niacin—atherosclerosis	0.000381	0.00171	CcSEcCtD
Terbinafine—Discomfort—Pravastatin—atherosclerosis	0.000379	0.0017	CcSEcCtD
Terbinafine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000378	0.00169	CcSEcCtD
Terbinafine—Decreased appetite—Lovastatin—atherosclerosis	0.000378	0.00169	CcSEcCtD
Terbinafine—Dyspepsia—Ezetimibe—atherosclerosis	0.000375	0.00168	CcSEcCtD
Terbinafine—Fatigue—Lovastatin—atherosclerosis	0.000375	0.00168	CcSEcCtD
Terbinafine—Anaphylactic shock—Niacin—atherosclerosis	0.000373	0.00167	CcSEcCtD
Terbinafine—Pain—Lovastatin—atherosclerosis	0.000372	0.00166	CcSEcCtD
Terbinafine—Confusional state—Pravastatin—atherosclerosis	0.000371	0.00166	CcSEcCtD
Terbinafine—Decreased appetite—Ezetimibe—atherosclerosis	0.000371	0.00166	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00037	0.00166	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000368	0.00165	CcSEcCtD
Terbinafine—Asthenia—Rosuvastatin—atherosclerosis	0.000368	0.00165	CcSEcCtD
Terbinafine—Anaphylactic shock—Pravastatin—atherosclerosis	0.000368	0.00165	CcSEcCtD
Terbinafine—Fatigue—Ezetimibe—atherosclerosis	0.000368	0.00165	CcSEcCtD
Terbinafine—Infection—Pravastatin—atherosclerosis	0.000365	0.00164	CcSEcCtD
Terbinafine—Paraesthesia—Simvastatin—atherosclerosis	0.000365	0.00163	CcSEcCtD
Terbinafine—Pain—Ezetimibe—atherosclerosis	0.000365	0.00163	CcSEcCtD
Terbinafine—Pruritus—Rosuvastatin—atherosclerosis	0.000363	0.00163	CcSEcCtD
Terbinafine—Skin disorder—Niacin—atherosclerosis	0.000363	0.00162	CcSEcCtD
Terbinafine—Thrombocytopenia—Pravastatin—atherosclerosis	0.00036	0.00161	CcSEcCtD
Terbinafine—Feeling abnormal—Lovastatin—atherosclerosis	0.000358	0.0016	CcSEcCtD
Terbinafine—Dyspepsia—Simvastatin—atherosclerosis	0.000358	0.0016	CcSEcCtD
Terbinafine—Anorexia—Niacin—atherosclerosis	0.000356	0.00159	CcSEcCtD
Terbinafine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000355	0.00159	CcSEcCtD
Terbinafine—Decreased appetite—Simvastatin—atherosclerosis	0.000353	0.00158	CcSEcCtD
Terbinafine—Feeling abnormal—Ezetimibe—atherosclerosis	0.000351	0.00157	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000351	0.00157	CcSEcCtD
Terbinafine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000351	0.00157	CcSEcCtD
Terbinafine—Fatigue—Simvastatin—atherosclerosis	0.000351	0.00157	CcSEcCtD
Terbinafine—Anorexia—Pravastatin—atherosclerosis	0.00035	0.00157	CcSEcCtD
Terbinafine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000349	0.00156	CcSEcCtD
Terbinafine—Pain—Simvastatin—atherosclerosis	0.000348	0.00156	CcSEcCtD
Terbinafine—Urticaria—Lovastatin—atherosclerosis	0.000345	0.00155	CcSEcCtD
Terbinafine—Abdominal pain—Lovastatin—atherosclerosis	0.000344	0.00154	CcSEcCtD
Terbinafine—Body temperature increased—Lovastatin—atherosclerosis	0.000344	0.00154	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00034	0.00152	CcSEcCtD
Terbinafine—Dizziness—Rosuvastatin—atherosclerosis	0.000339	0.00152	CcSEcCtD
Terbinafine—Urticaria—Ezetimibe—atherosclerosis	0.000339	0.00152	CcSEcCtD
Terbinafine—Body temperature increased—Ezetimibe—atherosclerosis	0.000337	0.00151	CcSEcCtD
Terbinafine—Abdominal pain—Ezetimibe—atherosclerosis	0.000337	0.00151	CcSEcCtD
Terbinafine—Paraesthesia—Niacin—atherosclerosis	0.000335	0.0015	CcSEcCtD
Terbinafine—Feeling abnormal—Simvastatin—atherosclerosis	0.000335	0.0015	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000335	0.0015	CcSEcCtD
Terbinafine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000332	0.00149	CcSEcCtD
Terbinafine—Paraesthesia—Pravastatin—atherosclerosis	0.00033	0.00148	CcSEcCtD
Terbinafine—Dyspepsia—Niacin—atherosclerosis	0.000329	0.00147	CcSEcCtD
Terbinafine—Decreased appetite—Niacin—atherosclerosis	0.000325	0.00145	CcSEcCtD
Terbinafine—Dyspepsia—Pravastatin—atherosclerosis	0.000324	0.00145	CcSEcCtD
Terbinafine—Rash—Rosuvastatin—atherosclerosis	0.000323	0.00145	CcSEcCtD
Terbinafine—Dermatitis—Rosuvastatin—atherosclerosis	0.000323	0.00145	CcSEcCtD
Terbinafine—Urticaria—Simvastatin—atherosclerosis	0.000323	0.00145	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Niacin—atherosclerosis	0.000322	0.00144	CcSEcCtD
Terbinafine—Abdominal pain—Simvastatin—atherosclerosis	0.000321	0.00144	CcSEcCtD
Terbinafine—Body temperature increased—Simvastatin—atherosclerosis	0.000321	0.00144	CcSEcCtD
Terbinafine—Headache—Rosuvastatin—atherosclerosis	0.000321	0.00144	CcSEcCtD
Terbinafine—Hypersensitivity—Lovastatin—atherosclerosis	0.00032	0.00143	CcSEcCtD
Terbinafine—Decreased appetite—Pravastatin—atherosclerosis	0.00032	0.00143	CcSEcCtD
Terbinafine—Pain—Niacin—atherosclerosis	0.000319	0.00143	CcSEcCtD
Terbinafine—Fatigue—Pravastatin—atherosclerosis	0.000317	0.00142	CcSEcCtD
Terbinafine—Pain—Pravastatin—atherosclerosis	0.000314	0.00141	CcSEcCtD
Terbinafine—Hypersensitivity—Ezetimibe—atherosclerosis	0.000314	0.00141	CcSEcCtD
Terbinafine—Asthenia—Lovastatin—atherosclerosis	0.000312	0.0014	CcSEcCtD
Terbinafine—Pruritus—Lovastatin—atherosclerosis	0.000308	0.00138	CcSEcCtD
Terbinafine—Asthenia—Ezetimibe—atherosclerosis	0.000306	0.00137	CcSEcCtD
Terbinafine—Gastrointestinal pain—Niacin—atherosclerosis	0.000305	0.00137	CcSEcCtD
Terbinafine—Nausea—Rosuvastatin—atherosclerosis	0.000305	0.00136	CcSEcCtD
Terbinafine—Feeling abnormal—Pravastatin—atherosclerosis	0.000303	0.00136	CcSEcCtD
Terbinafine—Pruritus—Ezetimibe—atherosclerosis	0.000302	0.00135	CcSEcCtD
Terbinafine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000301	0.00135	CcSEcCtD
Terbinafine—Hypersensitivity—Simvastatin—atherosclerosis	0.0003	0.00134	CcSEcCtD
Terbinafine—Diarrhoea—Lovastatin—atherosclerosis	0.000297	0.00133	CcSEcCtD
Terbinafine—Urticaria—Niacin—atherosclerosis	0.000297	0.00133	CcSEcCtD
Terbinafine—Body temperature increased—Niacin—atherosclerosis	0.000295	0.00132	CcSEcCtD
Terbinafine—Abdominal pain—Niacin—atherosclerosis	0.000295	0.00132	CcSEcCtD
Terbinafine—Urticaria—Pravastatin—atherosclerosis	0.000292	0.00131	CcSEcCtD
Terbinafine—Asthenia—Simvastatin—atherosclerosis	0.000292	0.00131	CcSEcCtD
Terbinafine—Diarrhoea—Ezetimibe—atherosclerosis	0.000292	0.00131	CcSEcCtD
Terbinafine—Body temperature increased—Pravastatin—atherosclerosis	0.000291	0.0013	CcSEcCtD
Terbinafine—Abdominal pain—Pravastatin—atherosclerosis	0.000291	0.0013	CcSEcCtD
Terbinafine—Pruritus—Simvastatin—atherosclerosis	0.000288	0.00129	CcSEcCtD
Terbinafine—Dizziness—Lovastatin—atherosclerosis	0.000287	0.00129	CcSEcCtD
Terbinafine—Dizziness—Ezetimibe—atherosclerosis	0.000282	0.00126	CcSEcCtD
Terbinafine—Diarrhoea—Simvastatin—atherosclerosis	0.000278	0.00125	CcSEcCtD
Terbinafine—Vomiting—Lovastatin—atherosclerosis	0.000276	0.00124	CcSEcCtD
Terbinafine—Hypersensitivity—Niacin—atherosclerosis	0.000275	0.00123	CcSEcCtD
Terbinafine—Rash—Lovastatin—atherosclerosis	0.000274	0.00123	CcSEcCtD
Terbinafine—Dermatitis—Lovastatin—atherosclerosis	0.000274	0.00123	CcSEcCtD
Terbinafine—Headache—Lovastatin—atherosclerosis	0.000272	0.00122	CcSEcCtD
Terbinafine—Vomiting—Ezetimibe—atherosclerosis	0.000271	0.00121	CcSEcCtD
Terbinafine—Hypersensitivity—Pravastatin—atherosclerosis	0.000271	0.00121	CcSEcCtD
Terbinafine—Dizziness—Simvastatin—atherosclerosis	0.000269	0.0012	CcSEcCtD
Terbinafine—Rash—Ezetimibe—atherosclerosis	0.000269	0.0012	CcSEcCtD
Terbinafine—Dermatitis—Ezetimibe—atherosclerosis	0.000269	0.0012	CcSEcCtD
Terbinafine—Asthenia—Niacin—atherosclerosis	0.000268	0.0012	CcSEcCtD
Terbinafine—Headache—Ezetimibe—atherosclerosis	0.000267	0.0012	CcSEcCtD
Terbinafine—Pruritus—Niacin—atherosclerosis	0.000264	0.00118	CcSEcCtD
Terbinafine—Asthenia—Pravastatin—atherosclerosis	0.000264	0.00118	CcSEcCtD
Terbinafine—Pruritus—Pravastatin—atherosclerosis	0.00026	0.00116	CcSEcCtD
Terbinafine—Vomiting—Simvastatin—atherosclerosis	0.000258	0.00116	CcSEcCtD
Terbinafine—Nausea—Lovastatin—atherosclerosis	0.000258	0.00116	CcSEcCtD
Terbinafine—Rash—Simvastatin—atherosclerosis	0.000256	0.00115	CcSEcCtD
Terbinafine—Dermatitis—Simvastatin—atherosclerosis	0.000256	0.00115	CcSEcCtD
Terbinafine—Diarrhoea—Niacin—atherosclerosis	0.000255	0.00114	CcSEcCtD
Terbinafine—Headache—Simvastatin—atherosclerosis	0.000255	0.00114	CcSEcCtD
Terbinafine—Nausea—Ezetimibe—atherosclerosis	0.000253	0.00113	CcSEcCtD
Terbinafine—Diarrhoea—Pravastatin—atherosclerosis	0.000251	0.00113	CcSEcCtD
Terbinafine—Dizziness—Niacin—atherosclerosis	0.000247	0.00111	CcSEcCtD
Terbinafine—Dizziness—Pravastatin—atherosclerosis	0.000243	0.00109	CcSEcCtD
Terbinafine—Nausea—Simvastatin—atherosclerosis	0.000241	0.00108	CcSEcCtD
Terbinafine—Vomiting—Niacin—atherosclerosis	0.000237	0.00106	CcSEcCtD
Terbinafine—Rash—Niacin—atherosclerosis	0.000235	0.00105	CcSEcCtD
Terbinafine—Dermatitis—Niacin—atherosclerosis	0.000235	0.00105	CcSEcCtD
Terbinafine—Headache—Niacin—atherosclerosis	0.000234	0.00105	CcSEcCtD
Terbinafine—Vomiting—Pravastatin—atherosclerosis	0.000234	0.00105	CcSEcCtD
Terbinafine—Rash—Pravastatin—atherosclerosis	0.000232	0.00104	CcSEcCtD
Terbinafine—Dermatitis—Pravastatin—atherosclerosis	0.000232	0.00104	CcSEcCtD
Terbinafine—Headache—Pravastatin—atherosclerosis	0.00023	0.00103	CcSEcCtD
Terbinafine—Nausea—Niacin—atherosclerosis	0.000222	0.000993	CcSEcCtD
Terbinafine—Nausea—Pravastatin—atherosclerosis	0.000218	0.000978	CcSEcCtD
Terbinafine—CYP2D6—Metabolism—APOA5—atherosclerosis	1.27e-05	7.74e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—APOB—atherosclerosis	1.27e-05	7.73e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—LDLR—atherosclerosis	1.27e-05	7.71e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.27e-05	7.69e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—APOA5—atherosclerosis	1.26e-05	7.67e-05	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—PTGS2—atherosclerosis	1.25e-05	7.6e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CYP27A1—atherosclerosis	1.25e-05	7.56e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—CETP—atherosclerosis	1.24e-05	7.53e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—GSTM1—atherosclerosis	1.24e-05	7.52e-05	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—AGT—atherosclerosis	1.24e-05	7.5e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.23e-05	7.45e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	1.23e-05	7.45e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.23e-05	7.44e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	1.22e-05	7.38e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—LPL—atherosclerosis	1.22e-05	7.38e-05	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—APOE—atherosclerosis	1.21e-05	7.35e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.2e-05	7.3e-05	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—CAV1—atherosclerosis	1.2e-05	7.28e-05	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—APOA1—atherosclerosis	1.2e-05	7.26e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.2e-05	7.26e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.19e-05	7.23e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.19e-05	7.23e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.19e-05	7.22e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—SCARB1—atherosclerosis	1.19e-05	7.22e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—GPX1—atherosclerosis	1.19e-05	7.2e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—ALOX5—atherosclerosis	1.18e-05	7.19e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—APOA2—atherosclerosis	1.18e-05	7.17e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	1.18e-05	7.17e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	1.18e-05	7.17e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—ALOX15—atherosclerosis	1.18e-05	7.17e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—ALOX5—atherosclerosis	1.17e-05	7.13e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—ABCG5—atherosclerosis	1.17e-05	7.08e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.16e-05	7.07e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.16e-05	7.03e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—NAMPT—atherosclerosis	1.16e-05	7.01e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—CD36—atherosclerosis	1.15e-05	7.01e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.15e-05	6.97e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—LIPC—atherosclerosis	1.15e-05	6.97e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.15e-05	6.96e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—APOC3—atherosclerosis	1.14e-05	6.93e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—LDLR—atherosclerosis	1.13e-05	6.89e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—LPA—atherosclerosis	1.13e-05	6.84e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—HMGCR—atherosclerosis	1.12e-05	6.81e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—CETP—atherosclerosis	1.11e-05	6.73e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—MTHFR—atherosclerosis	1.09e-05	6.64e-05	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—PIK3CG—atherosclerosis	1.09e-05	6.63e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—BGN—atherosclerosis	1.09e-05	6.62e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.09e-05	6.59e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.08e-05	6.57e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—APOA5—atherosclerosis	1.08e-05	6.55e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—FABP4—atherosclerosis	1.08e-05	6.55e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—LCAT—atherosclerosis	1.08e-05	6.55e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PPARA—atherosclerosis	1.07e-05	6.52e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—NAMPT—atherosclerosis	1.06e-05	6.45e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—SCARB1—atherosclerosis	1.06e-05	6.44e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—APOA4—atherosclerosis	1.06e-05	6.43e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—LIPC—atherosclerosis	1.06e-05	6.41e-05	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—PPARG—atherosclerosis	1.05e-05	6.4e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—NAMPT—atherosclerosis	1.05e-05	6.4e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—APOC3—atherosclerosis	1.05e-05	6.37e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.05e-05	6.37e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.05e-05	6.36e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—LIPC—atherosclerosis	1.05e-05	6.36e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—LDLR—atherosclerosis	1.04e-05	6.33e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—APOC3—atherosclerosis	1.04e-05	6.32e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.04e-05	6.31e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—AGT—atherosclerosis	1.04e-05	6.31e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	1.04e-05	6.31e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—LDLR—atherosclerosis	1.03e-05	6.28e-05	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—INS—atherosclerosis	1.03e-05	6.28e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.03e-05	6.27e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.03e-05	6.24e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—CETP—atherosclerosis	1.02e-05	6.19e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—APOE—atherosclerosis	1.02e-05	6.18e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.02e-05	6.18e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.02e-05	6.17e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.01e-05	6.15e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CETP—atherosclerosis	1.01e-05	6.13e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—CAV1—atherosclerosis	1.01e-05	6.13e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—APOA1—atherosclerosis	1.01e-05	6.11e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—ALOX5—atherosclerosis	1e-05	6.09e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—HMGCR—atherosclerosis	1e-05	6.08e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—ABCA1—atherosclerosis	1e-05	6.07e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—SCARB1—atherosclerosis	9.76e-06	5.92e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—SCARB1—atherosclerosis	9.67e-06	5.87e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CYP27A1—atherosclerosis	9.61e-06	5.83e-05	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—ALB—atherosclerosis	9.48e-06	5.75e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	9.42e-06	5.72e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	9.27e-06	5.63e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—HMGCR—atherosclerosis	9.21e-06	5.59e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PIK3CG—atherosclerosis	9.19e-06	5.58e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—HMGCR—atherosclerosis	9.13e-06	5.55e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	9.11e-06	5.53e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—APOA2—atherosclerosis	9.11e-06	5.53e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	9.11e-06	5.53e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—ALOX15—atherosclerosis	9.11e-06	5.53e-05	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—NOS3—atherosclerosis	9.07e-06	5.5e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	9.04e-06	5.49e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—NAMPT—atherosclerosis	9e-06	5.47e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—ABCG5—atherosclerosis	9e-06	5.46e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	8.95e-06	5.43e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—LIPC—atherosclerosis	8.95e-06	5.43e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—ABCA1—atherosclerosis	8.93e-06	5.42e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—APOC3—atherosclerosis	8.89e-06	5.4e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PPARG—atherosclerosis	8.87e-06	5.39e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—LDLR—atherosclerosis	8.84e-06	5.37e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—INS—atherosclerosis	8.7e-06	5.28e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—LPA—atherosclerosis	8.69e-06	5.28e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CETP—atherosclerosis	8.63e-06	5.24e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—HMOX1—atherosclerosis	8.58e-06	5.21e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—BGN—atherosclerosis	8.42e-06	5.11e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—APOA5—atherosclerosis	8.33e-06	5.06e-05	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—PTGS2—atherosclerosis	8.29e-06	5.03e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—SCARB1—atherosclerosis	8.27e-06	5.02e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	8.24e-06	5e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—APOB—atherosclerosis	8.22e-06	4.99e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—ABCA1—atherosclerosis	8.21e-06	4.99e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—ABCA1—atherosclerosis	8.14e-06	4.94e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	8.05e-06	4.89e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	8.02e-06	4.87e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—GSTM1—atherosclerosis	8e-06	4.86e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—ALB—atherosclerosis	7.98e-06	4.84e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—LPL—atherosclerosis	7.85e-06	4.77e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—HMGCR—atherosclerosis	7.81e-06	4.74e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—ALOX5—atherosclerosis	7.75e-06	4.7e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—HMOX1—atherosclerosis	7.66e-06	4.65e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—GPX1—atherosclerosis	7.66e-06	4.65e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—NOS3—atherosclerosis	7.63e-06	4.63e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—CD36—atherosclerosis	7.46e-06	4.53e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—APOB—atherosclerosis	7.34e-06	4.46e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—GSTM1—atherosclerosis	7.14e-06	4.33e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—MTHFR—atherosclerosis	7.07e-06	4.29e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—HMOX1—atherosclerosis	7.05e-06	4.28e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	7.04e-06	4.27e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—LPL—atherosclerosis	7.01e-06	4.25e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—HMOX1—atherosclerosis	6.99e-06	4.24e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PTGS2—atherosclerosis	6.98e-06	4.24e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—ABCA1—atherosclerosis	6.96e-06	4.22e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—NAMPT—atherosclerosis	6.95e-06	4.22e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PPARA—atherosclerosis	6.93e-06	4.21e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—LIPC—atherosclerosis	6.9e-06	4.19e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—APOC3—atherosclerosis	6.86e-06	4.17e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—GPX1—atherosclerosis	6.84e-06	4.15e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—LDLR—atherosclerosis	6.82e-06	4.14e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—APOB—atherosclerosis	6.75e-06	4.1e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—AGT—atherosclerosis	6.72e-06	4.08e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—APOB—atherosclerosis	6.69e-06	4.06e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CETP—atherosclerosis	6.66e-06	4.04e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—CD36—atherosclerosis	6.66e-06	4.04e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—APOE—atherosclerosis	6.58e-06	3.99e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—GSTM1—atherosclerosis	6.57e-06	3.99e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—CAV1—atherosclerosis	6.52e-06	3.96e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—GSTM1—atherosclerosis	6.51e-06	3.95e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—APOA1—atherosclerosis	6.5e-06	3.95e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—LPL—atherosclerosis	6.44e-06	3.91e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—LPL—atherosclerosis	6.39e-06	3.88e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—SCARB1—atherosclerosis	6.38e-06	3.87e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—MTHFR—atherosclerosis	6.31e-06	3.83e-05	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—AKT1—atherosclerosis	6.29e-06	3.82e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—GPX1—atherosclerosis	6.29e-06	3.82e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—GPX1—atherosclerosis	6.23e-06	3.78e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PPARA—atherosclerosis	6.19e-06	3.76e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—CD36—atherosclerosis	6.12e-06	3.72e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CD36—atherosclerosis	6.07e-06	3.69e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—HMGCR—atherosclerosis	6.02e-06	3.66e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—AGT—atherosclerosis	5.99e-06	3.64e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—HMOX1—atherosclerosis	5.97e-06	3.62e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PIK3CG—atherosclerosis	5.94e-06	3.61e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—APOE—atherosclerosis	5.87e-06	3.57e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—CAV1—atherosclerosis	5.82e-06	3.53e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—APOA1—atherosclerosis	5.81e-06	3.52e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—MTHFR—atherosclerosis	5.8e-06	3.52e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—MTHFR—atherosclerosis	5.75e-06	3.49e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PPARG—atherosclerosis	5.73e-06	3.48e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—APOB—atherosclerosis	5.72e-06	3.47e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PPARA—atherosclerosis	5.69e-06	3.46e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PPARA—atherosclerosis	5.64e-06	3.43e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—INS—atherosclerosis	5.62e-06	3.41e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—GSTM1—atherosclerosis	5.56e-06	3.38e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—AGT—atherosclerosis	5.51e-06	3.35e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—AGT—atherosclerosis	5.47e-06	3.32e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—LPL—atherosclerosis	5.46e-06	3.31e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—APOE—atherosclerosis	5.4e-06	3.28e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—ABCA1—atherosclerosis	5.37e-06	3.26e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—APOE—atherosclerosis	5.36e-06	3.25e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—CAV1—atherosclerosis	5.35e-06	3.25e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—APOA1—atherosclerosis	5.34e-06	3.24e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—GPX1—atherosclerosis	5.33e-06	3.23e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CAV1—atherosclerosis	5.31e-06	3.22e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PIK3CG—atherosclerosis	5.3e-06	3.22e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—APOA1—atherosclerosis	5.29e-06	3.21e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CD36—atherosclerosis	5.19e-06	3.15e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—ALB—atherosclerosis	5.15e-06	3.13e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PPARG—atherosclerosis	5.12e-06	3.11e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—INS—atherosclerosis	5.02e-06	3.05e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—NOS3—atherosclerosis	4.93e-06	2.99e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—MTHFR—atherosclerosis	4.92e-06	2.98e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PIK3CG—atherosclerosis	4.88e-06	2.96e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PIK3CG—atherosclerosis	4.83e-06	2.93e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PPARA—atherosclerosis	4.82e-06	2.93e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PPARG—atherosclerosis	4.71e-06	2.86e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—AGT—atherosclerosis	4.67e-06	2.84e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PPARG—atherosclerosis	4.66e-06	2.83e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—INS—atherosclerosis	4.61e-06	2.8e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—HMOX1—atherosclerosis	4.61e-06	2.8e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—ALB—atherosclerosis	4.6e-06	2.79e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—APOE—atherosclerosis	4.58e-06	2.78e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—INS—atherosclerosis	4.58e-06	2.78e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CAV1—atherosclerosis	4.53e-06	2.75e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—APOA1—atherosclerosis	4.52e-06	2.75e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PTGS2—atherosclerosis	4.51e-06	2.74e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—APOB—atherosclerosis	4.41e-06	2.68e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—NOS3—atherosclerosis	4.4e-06	2.67e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—GSTM1—atherosclerosis	4.29e-06	2.61e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—ALB—atherosclerosis	4.23e-06	2.57e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—LPL—atherosclerosis	4.21e-06	2.56e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—ALB—atherosclerosis	4.19e-06	2.55e-05	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—AKT1—atherosclerosis	4.17e-06	2.53e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PIK3CG—atherosclerosis	4.13e-06	2.51e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—GPX1—atherosclerosis	4.11e-06	2.5e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—NOS3—atherosclerosis	4.05e-06	2.46e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PTGS2—atherosclerosis	4.02e-06	2.44e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—NOS3—atherosclerosis	4.01e-06	2.44e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CD36—atherosclerosis	4e-06	2.43e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PPARG—atherosclerosis	3.99e-06	2.42e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—INS—atherosclerosis	3.91e-06	2.37e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—MTHFR—atherosclerosis	3.79e-06	2.3e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PPARA—atherosclerosis	3.72e-06	2.26e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PTGS2—atherosclerosis	3.7e-06	2.25e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PTGS2—atherosclerosis	3.67e-06	2.23e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—AGT—atherosclerosis	3.6e-06	2.19e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—ALB—atherosclerosis	3.58e-06	2.18e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—APOE—atherosclerosis	3.53e-06	2.14e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—AKT1—atherosclerosis	3.51e-06	2.13e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CAV1—atherosclerosis	3.5e-06	2.12e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—APOA1—atherosclerosis	3.49e-06	2.12e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—NOS3—atherosclerosis	3.43e-06	2.08e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PIK3CG—atherosclerosis	3.19e-06	1.94e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PTGS2—atherosclerosis	3.14e-06	1.9e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PPARG—atherosclerosis	3.08e-06	1.87e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—INS—atherosclerosis	3.02e-06	1.83e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—ALB—atherosclerosis	2.77e-06	1.68e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—NOS3—atherosclerosis	2.65e-06	1.61e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PTGS2—atherosclerosis	2.42e-06	1.47e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—AKT1—atherosclerosis	2.27e-06	1.38e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—AKT1—atherosclerosis	2.02e-06	1.23e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—AKT1—atherosclerosis	1.86e-06	1.13e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—AKT1—atherosclerosis	1.84e-06	1.12e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—AKT1—atherosclerosis	1.58e-06	9.57e-06	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—AKT1—atherosclerosis	1.22e-06	7.38e-06	CbGpPWpGaD
